Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20079207rdf:typepubmed:Citationlld:pubmed
pubmed-article:20079207lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20079207lifeskim:mentionsumls-concept:C0221002lld:lifeskim
pubmed-article:20079207lifeskim:mentionsumls-concept:C0020437lld:lifeskim
pubmed-article:20079207lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:20079207lifeskim:mentionsumls-concept:C1955566lld:lifeskim
pubmed-article:20079207lifeskim:mentionsumls-concept:C0231242lld:lifeskim
pubmed-article:20079207pubmed:issue9lld:pubmed
pubmed-article:20079207pubmed:dateCreated2010-1-18lld:pubmed
pubmed-article:20079207pubmed:abstractTextTo study the efficacy and adverse events of intravenous bisphosphonates in the treatment of patients of primary hyperparathyroidism (PHPT) complicated by hypercalcemia crisis.lld:pubmed
pubmed-article:20079207pubmed:languagechilld:pubmed
pubmed-article:20079207pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079207pubmed:citationSubsetIMlld:pubmed
pubmed-article:20079207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079207pubmed:statusMEDLINElld:pubmed
pubmed-article:20079207pubmed:monthSeplld:pubmed
pubmed-article:20079207pubmed:issn0578-1426lld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:JulMMlld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:GohY TYTlld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:QuY ZYZlld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:JiangYanYlld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:XingXiao-ping...lld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:MengXun-wuXWlld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:XiaWei-boWBlld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:LiuHuai-cheng...lld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:HuYing-yingYYlld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:CuiQuan-caiQClld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:WangOuOlld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:LianXiao-lanX...lld:pubmed
pubmed-article:20079207pubmed:authorpubmed-author:HanGui-yanGYlld:pubmed
pubmed-article:20079207pubmed:issnTypePrintlld:pubmed
pubmed-article:20079207pubmed:volume48lld:pubmed
pubmed-article:20079207pubmed:ownerNLMlld:pubmed
pubmed-article:20079207pubmed:authorsCompleteYlld:pubmed
pubmed-article:20079207pubmed:pagination729-33lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:meshHeadingpubmed-meshheading:20079207...lld:pubmed
pubmed-article:20079207pubmed:year2009lld:pubmed
pubmed-article:20079207pubmed:articleTitle[The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].lld:pubmed
pubmed-article:20079207pubmed:affiliationKey Laboratory of Endocrinology of Ministry of Health, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.lld:pubmed
pubmed-article:20079207pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20079207pubmed:publicationTypeEnglish Abstractlld:pubmed